@article{3a2cc962585a4dcb9c7e544ac6b1b949,
title = "Use of electronic health records and clinical decision support systems for antimicrobial stewardship",
abstract = "Electronic health records (EHRs) and clinical decision support systems (CDSSs) have the potential to enhance antimicrobial stewardship. Numerous EHRs and CDSSs are available and have the potential to enable all clinicians and antimicrobial stewardship programs (ASPs) to more efficiently review pharmacy, microbiology, and clinical data. Literature evaluating the impact of EHRs and CDSSs on patient outcomes is lacking, although EHRs with integrated CDSSs have demonstrated improvements in clinical and economic outcomes. Both technologies can be used to enhance existing ASPs and their implementation of core ASP strategies. Resolution of administrative, legal, and technical issues will enhance the acceptance and impact of these systems. EHR systems will increase in value when manufacturers include integrated ASP tools and CDSSs that do not require extensive commitment of information technology resources. Further research is needed to determine the true impact of current systems on ASP and the ultimate goal of improved patient outcomes through optimized antimicrobial use. ",
keywords = "antimicrobial stewardship, clinical decision support system, electronic health record",
author = "Forrest, {Graeme N.} and VanSchooneveld, {Trevor C} and Ravina Kullar and Schulz, {Lucas T.} and Phu Duong and Michael Postelnick",
note = "Funding Information: Disclaimer. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs. Acknowledgments. Editorial support was provided by ApotheCom ScopeMedical (Yardley, Pennsylvania) and funded by Cubist Pharmaceuticals. Supplement sponsorship. This article appears as part of a supplement titled “Antimicrobial Stewardship: Patients Over Process,” sponsored by Cubist Pharmaceuticals. Potential conflicts of interest. P. D. and R. K. are employees and stockholders of Cubist Pharmaceuticals. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. Funding Information: Funding to develop the Quality Compass (QC) PathFinder (Vecna Technologies, Inc, Cambridge, Massachusetts) came from a National Institutes of Health/National Institute of Allergy and Infectious Diseases grant. The initial version was an electronic infection surveillance software package that reported infection rates to the NHSN, generated healthcare-acquired infection alerts, created institutional or unit-specific real-time antibiograms, and reported pharmacy-related safety events. Publisher Copyright: {\textcopyright} The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.",
year = "2014",
month = oct,
day = "15",
doi = "10.1093/cid/ciu565",
language = "English (US)",
volume = "59",
pages = "S122--S133",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
}